[HTML][HTML] US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema

PJ Busse, SC Christiansen, MA Riedl, A Banerji… - The Journal of Allergy …, 2021 - Elsevier
Scientific and clinical progress together with the development of effective novel therapeutic
options has engendered multiple important changes in the diagnosis and management of …

The diagnosis and management of acute and chronic urticaria: 2014 update

JA Bernstein, DM Lang, DA Khan, T Craig… - Journal of Allergy and …, 2014 - Elsevier
These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP),
representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the …

Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency

K Bork, J Hardt, G Witzke - Journal of Allergy and Clinical Immunology, 2012 - Elsevier
BACKGROUND: Hereditary angioedema due to C1 inhibitor deficiency (HAE-C1-INH) is
characterized by relapsing skin swellings, abdominal pain attacks, and, less frequently …

Hereditary angioedema

BL Zuraw - New England Journal of Medicine, 2008 - Mass Medical Soc
A 19-year-old woman presents to the emergency department with light-headedness, severe
abdominal pain, and intractable nausea and vomiting that began 12 hours earlier. The …

Hereditary angioedema: new findings concerning symptoms, affected organs, and course

K Bork, G Meng, P Staubach, J Hardt - The American journal of medicine, 2006 - Elsevier
PURPOSE: Hereditary angioedema (HAE) due to C1 inhibitor deficiency is clinically
characterized by relapsing skin swellings, abdominal pain attacks, and life-threatening …

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology

ZH Israili, WD Hall - Annals of internal medicine, 1992 - acpjournals.org
▪ Objective: To review available information on cough and angioneurotic edema associated
with angiotensin-converting enzyme (ACE) inhibitors.▪ Data Sources: All relevant articles …

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

T Bowen, M Cicardi, H Farkas, K Bork… - Allergy, Asthma & …, 2010 - Springer
Abstract Background We published the Canadian 2003 International Consensus Algorithm
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …

Plasma bradykinin in angio-oedema

J Nussberger, M Cugno, C Amstutz, M Cicardi… - The Lancet, 1998 - thelancet.com
Background Bradykinin is believed to be the main mediator of symptoms in hereditary (HA)
and acquired (AA) angio-oedema due to C1 esterase inhibitor deficiency, as well as in angio …

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

A Agostoni, E Aygören-Pürsün, KE Binkley… - Journal of Allergy and …, 2004 - Elsevier
Hereditary angioedema (HAE), a rare but life-threatening condition, manifests as acute
attacks of facial, laryngeal, genital, or peripheral swelling or abdominal pain secondary to …

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema

BL Zuraw, PJ Busse, M White, J Jacobs… - … England Journal of …, 2010 - Mass Medical Soc
Background Hereditary angioedema due to C1 inhibitor deficiency is characterized by
recurrent acute attacks of swelling that can be painful and sometimes life-threatening …